| 2025 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| Revenue | 5,8 M € | — | — | |||
| Gross margin | 1,3 M € | -18.9% | 1,6 M € | -1.9% | 1,7 M € | |
| EBITDA | 488,7 k € | +53.2% | 319,0 k € | -41.8% | 547,9 k € | |
| Operating profit | 177,2 k € | +27.1% | 139,4 k € | +24.0% | 112,4 k € | |
| Profit/loss | 112,5 k € | +101.7% | 55,8 k € | +3467.3% | 1,6 k € | |
| Equity | 367,4 k € | +133.6% | 157,3 k € | +54.9% | 101,6 k € | |
| Total assets | 2,2 M € | -33.0% | 3,3 M € | -16.4% | 4,0 M € | |
| Cash | 332,0 k € | -12.6% | 380,1 k € | -51.5% | 783,4 k € | |
| Debts | 1,7 M € | -41.7% | 3,0 M € | -17.6% | 3,6 M € | |
| Staff | 4,6 | 6,7 | 8,4 | |||
Source: Belgian Official Gazette
Private limited company · Machelen (Brab.) · incorporated on 19/04/2021 · 4,6 ETP
Private limited company profitable and well capitalised. Cash position declining (-12.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Cordis Belgium is a Private limited company incorporated in 2021. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 4,6 ETP workers (FTE).